| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Technical Briefs |
1 Department of Biochemistry and Molecular Pharmacology Jefferson Center for Biomedical Research, Thomas Jefferson University, 700 E. Butler Ave., Doylestown, PA 18901
2 Departments of Internal Medicine and Pharmacology, 2150B Cancer and Geriatrics Center, University of Michigan Medical Center, Ann Arbor, MI
aauthor for correspondence: fax 215-489-4920, e-mail Yinghsiu.Su@jefferson.edu
| The first 20% of the full text of this article appears below. |
In the course of studying the incidence of k-ras mutations in DNA in the circulation of patients with colorectal disease, we observed that our ability to detect mutated k-ras DNA in serum varied with the method of DNA isolation. Two methods of DNA isolation were used in this study. One was the QIAamp DNA Blood Midi Kit (Qiagen, Inc.), which has been widely used for isolating circulating DNA from serum or plasma (1)(2)(3)(4)(5). The other is the modified Guanidine/Promega Resin (G/R) method that was developed to isolate DNA from urine (6).
To compare the applicability of the Qiagen and G/R methods for isolation of circulating DNA, we purified DNA from aliquots of serum from six patients with known mutant k-ras-positive colorectal disease (colorectal cancer or adenomatous polyps) and analyzed it for the presence of mutated k-ras DNA. As negative controls, serum samples from six patients with no detectable k-ras mutations in their disease tissues were subjected to DNA isolation and subsequently analyzed for k-ras mutations. Briefly, DNA from two aliquots of serum from each patient was isolated by the Qiagen method according to the manufacturer’s instructions or by the G/R method, as follows. Two volumes of 6 mol/L guanidine thiocyanate were mixed with the serum by inverting the mixture eight times. One milliliter of resin (from the Wizard DNA isolation reagent set; Promega) was then added, and the mixture was incubated for 2 h at room temperature with gentle mixing. The resin–DNA complex was transferred to a minicolumn (provided in the reagent set) and washed, and the DNA was eluted with H2O. Isolated DNA was quantified by real-time PCR on a LightCycler
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  S. L. Fong, J. T. Zhang, C. K. Lim, K. W. Eu, and Y. Liu Comparison of 7 Methods for Extracting Cell-Free DNA from Serum Samples of Colorectal Cancer Patients Clin. Chem., March 1, 2009; 55(3): 587 - 589. [Full Text] [PDF]
|
|
|
|
|
|
H. Mamon, C. Hader, J. Li, L. Wang, M. Kulke, G. Amicarelli, E. Shehi, D. Adlerstein, K. Roper, L. Killion, et al. Preferential Amplification of Apoptotic DNA from Plasma: Potential for Enhancing Detection of Minor DNA Alterations in Circulating DNA Clin. Chem., September 1, 2008; 54(9): 1582 - 1584. [Full Text] [PDF]
|
|
|
|
|
|
I. Muller, C. Beeger, C. Alix-Panabieres, X. Rebillard, K. Pantel, and H. Schwarzenbach Identification of Loss of Heterozygosity on Circulating Free DNA in Peripheral Blood of Prostate Cancer Patients: Potential and Technical Improvements Clin. Chem., April 1, 2008; 54(4): 688 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mora, E. Urgell, A. Farre, L. Comas, E. Montserrat, and F. Gonzalez-Sastre Agreement between K-ras Sequence Variations Detected in Plasma and Tissue DNA in Pancreatic and Colorectal Cancer. Clin. Chem., July 1, 2006; 52(7): 1448 - 1449. [Full Text] [PDF]
|
|
|
|
|
|
S. Trombino, M. Neri, R. Puntoni, C. Angelini, M. Loprevite, A. Cesario, P. Granone, A. Imperatori, L. Dominioni, A. Ardizzoni, et al. Mutations in K-ras Codon 12 Detected in Plasma DNA Are Not an Indicator of Disease in Patients with Non-Small Cell Lung Cancer Clin. Chem., July 1, 2005; 51(7): 1313 - 1314. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
